Viewing Study NCT03278132


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-01-02 @ 11:41 AM
Study NCT ID: NCT03278132
Status: COMPLETED
Last Update Posted: 2019-01-02
First Post: 2017-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine
Sponsor: Sinovac Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module